401 related articles for article (PubMed ID: 24763074)
21. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Trevino JG; Summy JM; Lesslie DP; Parikh NU; Hong DS; Lee FY; Donato NJ; Abbruzzese JL; Baker CH; Gallick GE
Am J Pathol; 2006 Mar; 168(3):962-72. PubMed ID: 16507911
[TBL] [Abstract][Full Text] [Related]
22. Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.
Fallacara AL; Passannanti R; Mori M; Iovenitti G; Musumeci F; Greco C; Crespan E; Kissova M; Maga G; Tarantelli C; Spriano F; Gaudio E; Bertoni F; Botta M; Schenone S
Eur J Med Chem; 2019 Nov; 181():111545. PubMed ID: 31400706
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.
Majid S; Saini S; Dar AA; Hirata H; Shahryari V; Tanaka Y; Yamamura S; Ueno K; Zaman MS; Singh K; Chang I; Deng G; Dahiya R
Cancer Res; 2011 Apr; 71(7):2611-21. PubMed ID: 21330408
[TBL] [Abstract][Full Text] [Related]
24. Src family kinases differentially influence glioma growth and motility.
Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
[TBL] [Abstract][Full Text] [Related]
25. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Montero JC; Seoane S; Ocaña A; Pandiella A
Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
[TBL] [Abstract][Full Text] [Related]
28. The role of Src family kinases in growth and migration of glioma stem cells.
Han X; Zhang W; Yang X; Wheeler CG; Langford CP; Wu L; Filippova N; Friedman GK; Ding Q; Fathallah-Shaykh HM; Gillespie GY; Nabors LB
Int J Oncol; 2014 Jul; 45(1):302-10. PubMed ID: 24819299
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness.
Ito H; Gardner-Thorpe J; Zinner MJ; Ashley SW; Whang EE
Surgery; 2003 Aug; 134(2):221-6. PubMed ID: 12947321
[TBL] [Abstract][Full Text] [Related]
30. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells.
Di Florio A; Capurso G; Milione M; Panzuto F; Geremia R; Delle Fave G; Sette C
Endocr Relat Cancer; 2007 Mar; 14(1):111-24. PubMed ID: 17395980
[TBL] [Abstract][Full Text] [Related]
31. Individual Src-family tyrosine kinases direct the degradation or protection of the clock protein Timeless via differential ubiquitylation.
O'Reilly LP; Zhang X; Smithgall TE
Cell Signal; 2013 Apr; 25(4):860-6. PubMed ID: 23266470
[TBL] [Abstract][Full Text] [Related]
32. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
33. S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion.
Rahman MA; Senga T; Ito S; Hyodo T; Hasegawa H; Hamaguchi M
J Biol Chem; 2010 Feb; 285(6):3806-3814. PubMed ID: 19948721
[TBL] [Abstract][Full Text] [Related]
34. Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.
Creeden JF; Alganem K; Imami AS; Henkel ND; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233470
[TBL] [Abstract][Full Text] [Related]
35. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
36. Activation of src-related tyrosine kinases by IL-3.
Anderson SM; Jorgensen B
J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
[TBL] [Abstract][Full Text] [Related]
37. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells.
Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
Urol Oncol; 2013 Apr; 31(3):343-51. PubMed ID: 21429770
[TBL] [Abstract][Full Text] [Related]
38. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Tyrosine Kinase FYN in Human Thyroid Carcinoma: Role in Modulating Tumor Cell Proliferation, Invasion, and Migration.
Zheng J; Li H; Xu D; Zhu H
Cancer Biother Radiopharm; 2017 Nov; 32(9):320-326. PubMed ID: 29140740
[TBL] [Abstract][Full Text] [Related]
40. PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses.
Samayawardhena LA; Pallen CJ
J Immunol; 2010 Nov; 185(10):5993-6002. PubMed ID: 20944008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
